Skip to product information
1 of 1

FDA ATROVENT NDA 020394 Approval Package — Reviews & Approval Records

FDA ATROVENT NDA 020394 Approval Package — Reviews & Approval Records

Regular price $169.00 USD
Regular price Sale price $169.00 USD
Sale Sold out

This FOIAdocs regulatory document collection brings together FDA approval records for ATROVENT, NDA 020394. The package contains 7 FDA documents totaling 235 pages, organized by original application and supplemental submission.

Research-ready collection with the FDA documents preserved as individual PDFs and organized by regulatory submission.

What's included

  • Original FDA approval records
  • 5 supplemental submissions represented
  • 2 FDA review documents
  • 4 approval letters
  • 1 labeling document
  • FOIAdocs document index and detailed manifest

Package format: Organized ZIP collection with individual FDA PDFs grouped by regulatory submission, plus a FOIAdocs document index and manifest.

Application: NDA 020394
Product: ATROVENT
Sponsor: BOEHRINGER INGELHEIM
Documents: 7
Pages: 235
Coverage: Original approval + 5 supplemental submissions represented

View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome